Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory J Dore

Showing results (301-310 of 404) with videos related to

Pageof 41
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 15, 2013
Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virusGail V Matthews, Eric C Seaberg, Anchalee Avihingsanon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 5, 2019
Moving Towards Hepatitis C Microelimination Among People Living With Human Immunodeficiency Virus in Australia: The CEASE StudyMarianne Martinello, Jasmine Yee, Sofia R Bartlett, et al.
International Journal of Epidemiology|December 4, 2012
Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) studyJason Grebely, Meghan D Morris, Thomas M Rice, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|December 4, 2015
HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infectionSofia R Bartlett, Brendan Jacka, Rowena A Bull, et al.
The International Journal on Drug Policy|March 24, 2024
96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trialMichael Farrell, Jeyran Shahbazi, Mark Chambers, et al.
Addiction (Abingdon, England)|July 24, 2018
Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugsJason Grebely, Sarah Larney, Amy Peacock, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 19, 2020
Progress Towards Elimination of Hepatitis C Infection Among People Who Inject Drugs in Australia: The ETHOS Engage StudyHeather Valerio, Maryam Alavi, David Silk, et al.
Drug and Alcohol Dependence|April 17, 2022
Willingness of people who inject drugs to participate in a randomised controlled trial involving financial incentives to initiate hepatitis C treatmentAlison D Marshall, Anna Conway, Evan B Cunningham, et al.
Viruses|November 27, 2024
A Pilot Randomised Controlled Trial Involving Financial Incentives to Facilitate Hepatitis C Treatment Uptake Among People Who Inject Drugs: ETHOS Engage StudyAlison D Marshall, Anna Conway, Evan B Cunningham, et al.
Annals of Clinical and Translational Neurology|June 15, 2023
The kynurenine pathway relates to post-acute COVID-19 objective cognitive impairment and PASCLucette A Cysique, David Jakabek, Sophia G Bracken, et al.
Pageof 41

Showing results (301-310 of 404) with videos related to

Sort By:
Pageof 41
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 15, 2013
Patterns and causes of suboptimal response to tenofovir-based therapy in individuals coinfected with HIV and hepatitis B virusGail V Matthews, Eric C Seaberg, Anchalee Avihingsanon, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 5, 2019
Moving Towards Hepatitis C Microelimination Among People Living With Human Immunodeficiency Virus in Australia: The CEASE StudyMarianne Martinello, Jasmine Yee, Sofia R Bartlett, et al.
International Journal of Epidemiology|December 4, 2012
Cohort profile: the international collaboration of incident HIV and hepatitis C in injecting cohorts (InC3) studyJason Grebely, Meghan D Morris, Thomas M Rice, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|December 4, 2015
HIV infection and hepatitis C virus genotype 1a are associated with phylogenetic clustering among people with recently acquired hepatitis C virus infectionSofia R Bartlett, Brendan Jacka, Rowena A Bull, et al.
The International Journal on Drug Policy|March 24, 2024
96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trialMichael Farrell, Jeyran Shahbazi, Mark Chambers, et al.
Addiction (Abingdon, England)|July 24, 2018
Global, regional, and country-level estimates of hepatitis C infection among people who have recently injected drugsJason Grebely, Sarah Larney, Amy Peacock, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 19, 2020
Progress Towards Elimination of Hepatitis C Infection Among People Who Inject Drugs in Australia: The ETHOS Engage StudyHeather Valerio, Maryam Alavi, David Silk, et al.
Drug and Alcohol Dependence|April 17, 2022
Willingness of people who inject drugs to participate in a randomised controlled trial involving financial incentives to initiate hepatitis C treatmentAlison D Marshall, Anna Conway, Evan B Cunningham, et al.
Viruses|November 27, 2024
A Pilot Randomised Controlled Trial Involving Financial Incentives to Facilitate Hepatitis C Treatment Uptake Among People Who Inject Drugs: ETHOS Engage StudyAlison D Marshall, Anna Conway, Evan B Cunningham, et al.
Annals of Clinical and Translational Neurology|June 15, 2023
The kynurenine pathway relates to post-acute COVID-19 objective cognitive impairment and PASCLucette A Cysique, David Jakabek, Sophia G Bracken, et al.
Pageof 41